Business Context and Reporting Period
Company: Herman Miller, Inc. (Note: Input metadata referenced "MillerKnoll," but filing text confirms "Herman Miller, Inc.")
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 4, 1995 (Third Quarter of Fiscal Year 1995)
Reporting Scope: Three months and nine months ended March 4, 1995, compared to the same periods ended February 26, 1994.
Key Financial Metrics
| Metric | Three Months Ended Mar 4, 1995 |
Nine Months Ended Mar 4, 1995 |
Three Months Ended Feb 26, 1994 |
Nine Months Ended Feb 26, 1994 |
|---|---|---|---|---|
| Net Sales ($000s) | $259,950 | $791,858 | $241,949 | $705,337 |
| Net Income ($000s) | $4,259 | $13,639 | $11,181 | $29,838 |
| Earnings Per Share | $0.17 | $0.55 | $0.44 | $1.18 |
| Gross Margin % | 34.2% | 35.3% | 34.8% | 34.7% |
| Operating Cash Flow ($000s) | Filing text does not provide a clear value for the three-month period. | $(246) | Filing text does not provide a clear value for the three-month period. | $49,921 |
| Total Interest-Bearing Debt ($000s) | $141,800 | $141,800 | $48,900 | $48,900 |
| Cash and Equivalents ($000s) | $22,589 | $22,589 | Filing text does not provide a clear value for the three-month period. | $22,639 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.4% in the quarter and 12.3% for the nine-month period, outpacing the industry average of 10%.
- Profitability Decline: Net income dropped 61.9% in the quarter and 54.3% for the nine months. This decline is primarily attributed to a $15.5 million pretax restructuring charge taken in the prior quarter (Q2 FY1995) and increased operating expenses.
- Debt Expansion: Total interest-bearing debt surged from $48.9 million to $141.8 million, driven by increased working capital needs and capital expenditures. Interest expense increased 500% in the quarter.
- Cash Flow Shift: Operating cash flow turned negative for the nine-month period ($(246) thousand) compared to a positive $49.9 million in the prior year, largely due to a $77.8 million increase in cash used for working capital.
- International Impact: International operations reported a net loss of $2.5 million for the quarter, worsened by a 46% devaluation of the Mexican peso, which reduced other income by $2.8 million.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Restructuring Benefits: The $15.5 million restructuring charge (facility closures in Fort Worth, Dayton, and Sanford) is expected to yield $0.8 million in savings in FY1995, growing to $20 million annually by FY1998. It will also increase unit production capacity by approximately 40%.
- New Product Launches: Management expects new products in seating, European furniture, and health-care areas to add 2-3% to net sales for the remainder of FY1995, with primary impact in Q4.
- Capital Expenditures: Projected capital spending for FY1995 has been raised to $65.0 million to support new processes and products.
- Debt Levels: Interest-bearing debt is expected to remain in the $140-$150 million range for the remainder of the fiscal year.
- Tax Rate: The effective tax rate for FY1995 is projected to be between 35% and 37%.
Risks and Contingencies
- Patent Litigation: Haworth, Inc. has sued Herman Miller alleging patent infringement regarding electrical systems. A jury trial is tentatively set for August 1995. Management believes it is more likely than not to prevail and does not expect a material adverse effect, though no absolute assurance exists.
- Product Recall Costs: Operating expenses included $1.8 million to repair approximately 70,000 mechanical height adjustments on Ergon 2 chairs.
- Currency Fluctuation: Continued devaluation of the Mexican peso could have further adverse effects on international results.
Investor Verification Checklist
- Verify the timeline and cost savings realization of the $15.5 million restructuring initiative.
- Monitor the outcome of the Haworth, Inc. patent infringement lawsuit scheduled for August 1995.
- Assess the impact of the Mexican peso devaluation on future international margins.
- Track the execution of the increased $65.0 million capital expenditure plan and its effect on cash flow.
- Confirm the sales contribution of new product launches in the fourth quarter to meet the 2-3% growth target.